Hypera (FRA:HM6A) Total Operating Expense: €442 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HM6A Hypera SA FRA:HM6A
92 GF Score
Price €3.50
GF Value €5.40
! 4 Warning Signs
View Full Analysis

What is Hypera Total Operating Expense?

Hypera FRA:HM6A +3.55% 92 Total Operating Expense is €442 Mil as of Mar. 2026. GuruFocus rates FRA:HM6A with a GF Score™ of 92/100 and a GF Value™ of €5.40. The stock has 4 warning signs investors should review.

Hypera's Total Operating Expense for the three months ended in Mar. 2026 was €117 Mil. Hypera's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €442 Mil.

Hypera Total Operating Expense Related Terms

Hypera Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Hypera's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypera Total Operating Expense Chart

Hypera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 289.64 414.32 467.43 404.67 439.46

Hypera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.10 101.89 110.06 113.93 116.56
FRA:HM6A
92GF Score
Hypera SA FRA:HM6A
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hypera Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €442 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €442 Mil mean?
Hypera (FRA:HM6A) has a Total Operating Expense of €442 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Hypera and its competitors.
Is Hypera's Total Operating Expense too high?
Hypera's current Total Operating Expense is €442 Mil. Overall, Hypera has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Hypera's Total Operating Expense compare to ZTS and UTHR?
Hypera's Total Operating Expense of €442 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Hypera and its competitors. Hypera's current Total Operating Expense is €442 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypera stock overvalued right now?
Hypera (FRA:HM6A) has a current Total Operating Expense of €442 Mil. The stock's GF Value™ is €5.40, compared to a current price of €3.50 — trading 35.2% below its estimated fair value. The current Total Operating Expense is €442 Mil. Hypera's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Hypera (FRA:HM6A), the current Total Operating Expense is €442 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hypera (FRA:HM6A) Overvalued in 2026?

Based on GuruFocus' analysis, Hypera stock appears to be undervalued. The current stock price of €3.50 is trading 35.2% below its estimated GF Value™ of €5.40.

Key valuation signals for FRA:HM6A:

  • Total Operating Expense: €442 Mil
  • GF Value™: €5.40 vs. price of €3.50 (35.2% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the FRA:HM6A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hypera Business Description

Address Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
92GF Score

Get the complete analysis for FRA:HM6A

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.50
Price
€5.40
GF Value